Given that SREBP2 and RANKL are both involved in disorders of cholesterol metabolism in non-obese subjects with NAFLD, we boldly speculate that SREBP2 might mediate the role of RANKL in NAFLD in young PCOS women with normal weight. This evidence concerns the gene SREBF2 and metabolic dysfunction-associated steatotic liver disease.